Table 2.

Logistic regression analysis for risk association between depression (GDS score ≥7) and control of cardiometabolic risk factors and co-morbidities in Chinese elderly patients with type 2 diabetes.

		Odds ratio (95% confidence interval)	P-value
Blood pressure <130/80 mmHg target attainment	Model 1	0.330 (0.133–0.823)	0.017*
	Model 2	0.323 (0.127–0.819)	0.017*
	Model 3	0.301 (0.121–0.748)	0.010*
	Model 4	0.292 (0.118–0.726)	0.008*
HbA1c <7.0% target attainment	Model 1	0.349 (0.168–0.724)	0.005*
	Model 2	0.441 (0.201–0.968)	0.041*
	Model 3	0.409 (0.188–0.890)	0.024*
	Model 4	0.400 (0.188–0.853)	0.018*
History of any co-morbiditiesa	Model 1	2.844 (1.347–6.002)	0.006*
	Model 2	2.559 (1.178–5.562)	0.018*
	Model 3	2.850 (1.349–6.021)	0.006*
	Model 4	2.853 (1.354–6.013)	0.006*

Model 1: Adjusted for age, gender and use of anti-hypertensive drugs.

Model 2: Adjusted for age, gender, use of anti-diabetic drugs, insulin, lipid lowering drugs and anti-hypertensive drugs.

Model 3: Adjusted for age, gender, use of anti-diabetic drugs, and use of insulin.

Model 4: adjusted for age, gender, and duration of diabetes.

*denotes P-value < 0.05.

^aAny comorbidities including cardiovascular, chronic kidney disease, and any form of cancer.